Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Non-Current Deferred Tax Liability (2014 - 2017)

Updated

Immucell's Non-Current Deferred Tax Liability was $57,574 in Q1 2017.

Analysis

Immucell (ICCC) Non-Current Deferred Tax Liability (2014 - 2017) Analysis & Trends

  • The Q1 2017 figure marks the lowest quarterly Non-Current Deferred Tax Liability since Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 57,574.00
Sep 30, 2014 24,688.00
Jun 30, 2014 23,749.00
API Access

Immucell Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ICCC&period=max&api_key=YOUR_API_KEY